Rallybio Corporation
RLYB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $16,016 | -$9,703 | -$9,439 | -$11,044 |
| Dep. & Amort. | $35 | $26 | $28 | $30 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,047 | $1,614 | $1,879 | $1,963 |
| Change in WC | -$1,185 | -$450 | -$3,050 | -$925 |
| Other Non-Cash | -$22,463 | $134 | $377 | $114 |
| Operating Cash Flow | -$6,550 | -$8,379 | -$10,205 | -$9,862 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $20,000 | $1,000 | -$1,000 | $0 |
| Inv. Purchases | -$738 | -$3,965 | -$5,919 | -$17,324 |
| Inv. Sales/Matur. | $9,965 | $7,500 | $18,000 | $15,751 |
| Other Inv. Act. | $0 | -$1,500 | $0 | $0 |
| Investing Cash Flow | $29,227 | $3,035 | $11,081 | -$1,573 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $10 | $0 | $18 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $10 | $0 | $18 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $22,677 | -$5,334 | $876 | -$11,417 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,445 | $14,779 | $13,903 | $25,320 |
| End Cash | $32,122 | $9,445 | $14,779 | $13,903 |
| Free Cash Flow | -$6,550 | -$8,379 | -$10,205 | -$9,862 |